These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 20572032)
1. Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology Program. Minasian LM; Carpenter WR; Weiner BJ; Anderson DE; McCaskill-Stevens W; Nelson S; Whitman C; Kelaghan J; O'Mara AM; Kaluzny AD Cancer; 2010 Oct; 116(19):4440-9. PubMed ID: 20572032 [TBL] [Abstract][Full Text] [Related]
2. A method for analyzing the business case for provider participation in the National Cancer Institute's Community Clinical Oncology Program and similar federally funded, provider-based research networks. Reiter KL; Song PH; Minasian L; Good M; Weiner BJ; McAlearney AS Cancer; 2012 Sep; 118(17):4253-61. PubMed ID: 22213241 [TBL] [Abstract][Full Text] [Related]
3. The NCI Community Oncology Research Program: what every clinician needs to know. McCaskill-Stevens W; Lyss AP; Good M; Marsland T; Lilenbaum R Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714464 [TBL] [Abstract][Full Text] [Related]
4. Why providers participate in clinical trials: considering the National Cancer Institute's Community Clinical Oncology Program. McAlearney AS; Song PH; Reiter KL Contemp Clin Trials; 2012 Nov; 33(6):1143-9. PubMed ID: 22925970 [TBL] [Abstract][Full Text] [Related]
5. Reforming the community research program: from Community Clinical Oncology Program to the National Cancer Institute Community Oncology Research Program. Zon RT Am Soc Clin Oncol Educ Book; 2014; ():e116-9. PubMed ID: 24857089 [TBL] [Abstract][Full Text] [Related]
6. National Cancer Institute: Restructuring to Support the Clinical Trials of the Future. Good M; Castro K; Denicoff A; Finnigan S; Parreco L; Germain DS Semin Oncol Nurs; 2020 Apr; 36(2):151003. PubMed ID: 32265163 [TBL] [Abstract][Full Text] [Related]
7. National Heart, Lung, and Blood Institute and the translation of cardiovascular discoveries into therapeutic approaches. Galis ZS; Black JB; Skarlatos SI Circ Res; 2013 Apr; 112(9):1212-8. PubMed ID: 23620235 [TBL] [Abstract][Full Text] [Related]
8. The NCI All Ireland Cancer Conference. Johnston PG; Daly PA; Liu E Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862 [TBL] [Abstract][Full Text] [Related]
9. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology. Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736 [TBL] [Abstract][Full Text] [Related]
10. National Cancer Institute Alliance for nanotechnology in cancer-Catalyzing research and translation toward novel cancer diagnostics and therapeutics. Hartshorn CM; Russell LM; Grodzinski P Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov; 11(6):e1570. PubMed ID: 31257722 [TBL] [Abstract][Full Text] [Related]
12. Capacity for Cancer Care Delivery Research in National Cancer Institute Community Oncology Research Program Community Practices: Availability of Radiology and Primary Care Research Partners. Carlos RC; Sicks JD; Chang GJ; Lyss AP; Stewart TL; Sung L; Weaver KE J Am Coll Radiol; 2017 Dec; 14(12):1530-1537. PubMed ID: 29055605 [TBL] [Abstract][Full Text] [Related]
13. Establishing a minority-based community clinical oncology program: the University of Medicine and Dentistry of New Jersey, New Jersey Medical School-university Hospital Cancer Center experience. Wieder R; Teal R; Saunders T; Weiner BJ J Oncol Pract; 2013 Mar; 9(2):e48-54. PubMed ID: 23814524 [TBL] [Abstract][Full Text] [Related]
14. From the editor. Translational Research Working Group roadmaps for cancer research. Bates SE Clin Cancer Res; 2008 Sep; 14(18):5663. PubMed ID: 18794073 [No Abstract] [Full Text] [Related]
15. Provider-based research networks and diffusion of surgical technologies among patients with early-stage kidney cancer. Tan HJ; Meyer AM; Kuo TM; Smith AB; Wheeler SB; Carpenter WR; Nielsen ME Cancer; 2015 Mar; 121(6):836-43. PubMed ID: 25410684 [TBL] [Abstract][Full Text] [Related]
16. Expanding public-private collaborations to enhance cancer drug development: a report of the Institute of Medicine's workshop series, "Implementing a National Cancer Clinical Trials System for the 21st Century". Bertagnolli MM; Canetta R; Nass SJ Oncologist; 2014 Nov; 19(11):1179-85. PubMed ID: 25326161 [TBL] [Abstract][Full Text] [Related]
17. Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology. Patel JD; Krilov L; Adams S; Aghajanian C; Basch E; Brose MS; Carroll WL; de Lima M; Gilbert MR; Kris MG; Marshall JL; Masters GA; O'Day SJ; Polite B; Schwartz GK; Sharma S; Thompson I; Vogelzang NJ; Roth BJ J Clin Oncol; 2014 Jan; 32(2):129-60. PubMed ID: 24327669 [TBL] [Abstract][Full Text] [Related]
18. The role of organizational affiliations and research networks in the diffusion of breast cancer treatment innovation. Carpenter WR; Reeder-Hayes K; Bainbridge J; Meyer AM; Amos KD; Weiner BJ; Godley PA Med Care; 2011 Feb; 49(2):172-9. PubMed ID: 21206296 [TBL] [Abstract][Full Text] [Related]
19. Evolution of the "drivers" of translational cancer epidemiology: analysis of funded grants and the literature. Lam TK; Chang CQ; Rogers SD; Khoury MJ; Schully SD Am J Epidemiol; 2015 Apr; 181(7):451-8. PubMed ID: 25767265 [TBL] [Abstract][Full Text] [Related]